Replies to post #12975 on CV Sciences Inc (CVSI)

[jefra1965]

The $2.50 (P/S = 9.06) will come next week.

Here is the math:

In June 27 Epidiolex will get approved by the FDA. That's 20 days from now. CVSI current P/S valuation @ $1.85 is 6.7. Just too cheap for the potential of the CBD industry and the best in breed company in retail CBD.

GWPH, owner of Epidiolex is valued @ P/S of 200+ That's right TWO HUNDRED PLUS. More than 20 times and GO CHECK their balance sheet. And CBD is CBD no matter how you take it or mix it, it is the same molecule..

In about 67 days from now the next 10Q (Q2'18) comes out. The next 10Q will bump TTM revenues to about $29.5 Mill. This will cause an adjustment in the P/S valuation (a decrease) that makes $2.50 (P/S of 9.06) just fair. The price can easily trend up from there.

So I'm sure it will surpass the $3.00 level before the approval of the new drug.